🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to assess the bioavailability (the extent to wh...
Status
Completed
Location
Multiple Locations
Start Date
2014-03
Trial ID
NCT02079545
Sirukumab is a fully human anti-interleukin-6 (IL-6) immunoglobulin G1-kapp...
Status
Terminated
Location
GSK Investigational Site
Start Date
2015-10-16
Trial ID
NCT02531633
Treatments Being Tested
The purpose of this study is to evaluate the long-term safety and efficacy ...
Status
Completed
Location
Multiple Locations
Start Date
2013-08-07
Trial ID
NCT01856309
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of sirukum...
Status
Completed
Location
Multiple Locations
Start Date
2012-11
Trial ID
NCT01689532
Treatments Being Tested
The purpose of this study is to assess the efficacy of sirukumab as measure...
Status
Completed
Location
Multiple Locations
Start Date
2012-08-15
Trial ID
NCT01604343
The main purpose of this study is to evaluate the potential effects of a si...
Status
Completed
Location
Multiple Locations
Start Date
2012-10-11
Trial ID
NCT01636557
Sirukumab is a human anti-IL-6 monoclonal antibody that selectively binds t...
Status
Withdrawn
Location
Multiple Locations
Start Date
2018-03-15
Trial ID
NCT02899026
Treatments Being Tested
The purpose of this study is to evaluate the effectiveness and safety of su...
Status
Completed
Location
Multiple Locations
Start Date
2008-08-11
Trial ID
NCT00718718
Treatments Being Tested
The purpose of this study is to assess the efficacy of sirukumab as measure...
Status
Completed
Location
Multiple Locations
Start Date
2012-08-06
Trial ID
NCT01606761
The primary objective is to investigate the efficacy of sirukumab monothera...
Status
Completed
Location
Multiple Locations
Start Date
2014-04-04
Trial ID
NCT02019472
Treatments Being Tested